Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
Trial ID or NCT#
NCT02025543
Status
NOT RECRUITING
Purpose
The purpose of this multi-site ÌÇÐÄ´«Ã½ is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.
Official Title
Confounder-Corrected Quantitative Magnetic Resonance Imaging (MRI) Biomarker of Hepatic Iron Content
Eligibility Criteria
Ages Eligible for Study: 8 Years to 89 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
- * know or suspected iron overload* minimum age: Stanford- 8years , University of Wisconsin - 10 years, John Hopkins follow- 10 years, University of Texas-Southwestern - 18 years
Exclusion Criteria:
- * contraindication to magnetic resonance imaging
Investigator(s)
ShreyasÌýVasanawala, MD/PhD
Radiologist
William R. Brody Professor of Pediatric Radiology and Child Health
Contact us to find out if this trial is right for you.
Contact
Elisabeth Merkel, RN
650-736-0644
View on